Protein Tyrosine Kinases
From Inhibitors to Useful Drugs
(Sprache: Englisch)
Leading researchers, from the Novartis group that pioneered Gleevec/Glivec(TM) and around the world, comprehensively survey the state of the art in the drug discovery processes (bio- and chemoinformatics, structural biology, profiling, generation of...
Leider schon ausverkauft
versandkostenfrei
Buch
Fr. 353.90
inkl. MwSt.
- Kreditkarte, Paypal, Rechnungskauf
- 30 Tage Widerrufsrecht
Produktdetails
Produktinformationen zu „Protein Tyrosine Kinases “
Klappentext zu „Protein Tyrosine Kinases “
Leading researchers, from the Novartis group that pioneered Gleevec/Glivec(TM) and around the world, comprehensively survey the state of the art in the drug discovery processes (bio- and chemoinformatics, structural biology, profiling, generation of resistance, etc.) aimed at generating PTK inhibitors for the treatment of various diseases, including cancer. Highlights include a discussion of the rationale and the progress made towards generating "selective" low molecular-weight kinase inhibitors; an analysis of the normal function, role in disease, and application of platelet-derived growth factor antagonists; and a summary of the factors involved in successful structure-based drug design. Additional chapters address the advantages and disadvantages of in vivo preclinical models for testing protein kinase inhibitors with antitumor activity and the utility of different methods in the drug discovery and development process for determining "on-target" vs "off-target" effects of kinase inhibitors.
Inhaltsverzeichnis zu „Protein Tyrosine Kinases “
- Protein Tyrosine Kinases as Targets for Cancer and Other Indications - Inhibitors of Signaling Interfaces: Targeting Src Homology 2 Domains in Drug Discovery
- PI3-Kinase Inhibition: A Target for Therapeutic Intervention
- Src as a Target for Pharmaceutical Intervention: Potential and Limitations
- Activated FLT3 Receptor Tyrosine Kinase as a Therapeutic Target in Leukemia
- JAK Kinases in Leukemias, Lymphomas, and Multiple Myeloma
- Glivec® (Gleevec®, Imatinib, STI571): A Targeted Therapy for Chronic Myelogenous Leukemia
- Platelet-Derived Growth Factor: Normal Function, Role in Disease, and Application of PDGF Antagonists
- Structural Biology of Protein Tyrosine Kinases
- Testing of Signal Transduction Inhibitors in Animal Models of Cancer
- Phosphoproteomics in Drug Discovery and Development
- Index
Bibliographische Angaben
- 2005, 290 Seiten, Masse: 16,1 x 23,6 cm, Gebunden, Englisch
- Herausgegeben:McCormick, Frank; Fabbro, Doriano
- Herausgegeben: Doriano Fabbro, Frank McCormick
- Verlag: Humana Press
- ISBN-10: 158829384X
- ISBN-13: 9781588293848
- Erscheinungsdatum: 01.09.2005
Sprache:
Englisch
Kommentar zu "Protein Tyrosine Kinases"
0 Gebrauchte Artikel zu „Protein Tyrosine Kinases“
| Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
|---|
Schreiben Sie einen Kommentar zu "Protein Tyrosine Kinases".
Kommentar verfassen